22 2023.09

[Other] Notification Letter and Request Form to Non-Registered Holders - Notice of Publication of 2023 Interim Report ("Current Corporate Communications")

22 2023.09

[Interim/Half-Year Report] 2023 Interim Report

11 2023.09

[Final Results / Other - Miscellaneous] SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO 2022 ANNUAL REPORT

06 2023.09

Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023

04 2023.09

[Overseas Regulatory Announcement - Corporate Governance Related Matters / Overseas Regulatory Announcement-Other] An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

04 2023.09

[Change in Directors or of Important Executive Functions or Responsibilities / Change in Company Secretary] RESIGNATION OF CHIEF FINANCIAL OFFICER AND JOINT COMPANY SECRETARY

22 2023.08

[Other - Business Update] VOLUNTARY ANNOUNCEMENT-RESULTS OF PHASE III STUDY ON TELITACICEPT FOR TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN CHINA

22 2023.08

[Interim Results / Revision of Information in Published Preliminary Results] CLARIFICATION ANNOUNCEMENT IN RELATION TO THE INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023

21 2023.08

[Overseas Regulatory Announcement - Other] An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

21 2023.08

[Overseas Regulatory Announcement - Trading Update] An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section